It is expected that the appeals court will overturn the decision. This ruling is the latest development in a long-running legal battle over claims that talc in Johnson's Baby powder and Shower to Shower body powder was linked to ovarian cancer and mesothelioma, an aggressive cancer that affects the lungs and other organs. Johnson & Johnson stopped selling talc-based products worldwide in 2023. The company said it would appeal the verdict. During a 13-day trial in Ramsey County Court, Carly's legal team argued that the pharmaceutical giant sold and marketed talc-based products to consumers despite knowing they could be contaminated with asbestos. Carly's lawyers also said her family was never warned of the potential risks when using the product on their child. On Friday, a Minnesota jury awarded $65.5 million in damages to a mother of three who claimed Johnson & Johnson's talc products exposed her to asbestos and contributed to her developing cancer of the lung lining. The jury found that 37-year-old Anna Jean Houghton Carly should receive compensation from Johnson & Johnson after using the company's baby powder throughout her childhood and later developing mesothelioma, an aggressive cancer primarily caused by exposure to carcinogenic asbestos. The product was pulled from shelves in the U.S. in 2020. Ben Braly, Carly's attorney, said: 'This case wasn't just about monetary compensation, it was about truth and accountability.' Meanwhile, Eric Haas, vice president of litigation for Johnson & Johnson, argued that the company's baby powder is safe, asbestos-free, and does not cause cancer.
